dacarbazine has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Günay, U; Meral, A; Ozkan, T; Ozuysal, S; Sevinir, B; Sinirtas, M | 1 |
| Donley, K; Grgurević, I; Kujundzić, M; Martinović, M; Pavletic, S; Pejsa, V; Stancić, V | 1 |
2 other study(ies) available for dacarbazine and Chronic Hepatitis C
| Article | Year |
|---|---|
Increased risk of chronic hepatitis in children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; DNA, Viral; Doxorubicin; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Infant; Infant, Newborn; Liver Function Tests; Male; Neoplasms; Polymerase Chain Reaction; Risk Factors; RNA, Viral; Vinblastine | 2003 |
No adverse effect of ABVD chemotherapy in a patient with chronic hepatitis C and Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combat Disorders; Croatia; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hepatitis C, Chronic; Hodgkin Disease; Humans; Liver; Liver Function Tests; Neoplasm Staging; Remission Induction; Substance Abuse, Intravenous; Vinblastine | 2004 |